ジーエヌアイグループの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2024/07/24 | 2,272 | 2,332 | 2,232 | 2,233 | -53 | -2.3% | 666,300 |
| 2024/07/23 | 2,295 | 2,314 | 2,218 | 2,286 | +8 | +0.4% | 889,100 |
| 2024/07/22 | 2,410 | 2,424 | 2,273 | 2,278 | -157 | -6.4% | 1,289,000 |
| 2024/07/19 | 2,571 | 2,594 | 2,433 | 2,435 | -156 | -6% | 1,065,600 |
| 2024/07/18 | 2,665 | 2,710 | 2,510 | 2,591 | -92 | -3.4% | 1,823,600 |
| 2024/07/17 | 2,633 | 2,703 | 2,623 | 2,683 | +125 | +4.9% | 1,011,900 |
| 2024/07/16 | 2,584 | 2,609 | 2,555 | 2,558 | +21 | +0.8% | 773,300 |
| 2024/07/12 | 2,441 | 2,554 | 2,438 | 2,537 | +96 | +3.9% | 848,700 |
| 2024/07/11 | 2,450 | 2,475 | 2,430 | 2,441 | +16 | +0.7% | 492,200 |
| 2024/07/10 | 2,454 | 2,457 | 2,365 | 2,425 | -21 | -0.9% | 667,900 |
| 2024/07/09 | 2,470 | 2,507 | 2,431 | 2,446 | -20 | -0.8% | 746,700 |
| 2024/07/08 | 2,464 | 2,468 | 2,397 | 2,466 | +30 | +1.2% | 460,300 |
| 2024/07/05 | 2,385 | 2,453 | 2,348 | 2,436 | +57 | +2.4% | 648,800 |
| 2024/07/04 | 2,351 | 2,408 | 2,339 | 2,379 | +37 | +1.6% | 501,900 |
| 2024/07/03 | 2,290 | 2,342 | 2,282 | 2,342 | +55 | +2.4% | 496,200 |
| 2024/07/02 | 2,350 | 2,369 | 2,279 | 2,287 | -53 | -2.3% | 751,600 |
| 2024/07/01 | 2,419 | 2,438 | 2,340 | 2,340 | -29 | -1.2% | 1,046,800 |
| 2024/06/28 | 2,450 | 2,450 | 2,352 | 2,369 | -81 | -3.3% | 787,000 |
| 2024/06/27 | 2,325 | 2,525 | 2,325 | 2,450 | +125 | +5.4% | 1,511,800 |
| 2024/06/26 | 2,371 | 2,371 | 2,303 | 2,325 | -50 | -2.1% | 609,300 |
| 2024/06/25 | 2,365 | 2,403 | 2,336 | 2,375 | +22 | +0.9% | 606,500 |
| 2024/06/24 | 2,431 | 2,466 | 2,353 | 2,353 | -107 | -4.3% | 902,900 |
| 2024/06/21 | 2,458 | 2,506 | 2,446 | 2,460 | +3 | +0.1% | 936,700 |
| 2024/06/20 | 2,350 | 2,457 | 2,346 | 2,457 | +131 | +5.6% | 1,118,000 |
| 2024/06/19 | 2,303 | 2,335 | 2,265 | 2,326 | +16 | +0.7% | 570,000 |
| 2024/06/18 | 2,376 | 2,395 | 2,305 | 2,310 | -65 | -2.7% | 943,000 |
| 2024/06/17 | 2,290 | 2,376 | 2,283 | 2,375 | +85 | +3.7% | 930,800 |
| 2024/06/14 | 2,173 | 2,323 | 2,173 | 2,290 | +67 | +3% | 768,600 |
| 2024/06/13 | 2,262 | 2,335 | 2,223 | 2,223 | -24 | -1.1% | 894,200 |
| 2024/06/12 | 2,257 | 2,283 | 2,230 | 2,247 | -6 | -0.3% | 394,100 |
| 2024/06/11 | 2,216 | 2,277 | 2,211 | 2,253 | +69 | +3.2% | 886,200 |
| 2024/06/10 | 2,158 | 2,185 | 2,115 | 2,184 | +12 | +0.6% | 618,000 |
| 2024/06/07 | 2,094 | 2,172 | 2,093 | 2,172 | +68 | +3.2% | 352,800 |
| 2024/06/06 | 2,135 | 2,146 | 2,089 | 2,104 | -19 | -0.9% | 541,800 |
| 2024/06/05 | 2,151 | 2,174 | 2,108 | 2,123 | -39 | -1.8% | 491,600 |
| 2024/06/04 | 2,156 | 2,217 | 2,127 | 2,162 | -12 | -0.6% | 661,700 |
| 2024/06/03 | 2,206 | 2,212 | 2,161 | 2,174 | -29 | -1.3% | 507,200 |
| 2024/05/31 | 2,134 | 2,256 | 2,124 | 2,203 | +86 | +4.1% | 1,297,900 |
| 2024/05/30 | 2,095 | 2,139 | 2,080 | 2,117 | +20 | +1% | 911,900 |
| 2024/05/29 | 2,120 | 2,140 | 2,068 | 2,097 | -3 | -0.1% | 660,200 |
| 2024/05/28 | 2,136 | 2,182 | 2,100 | 2,100 | +14 | +0.7% | 1,048,900 |
| 2024/05/27 | 2,071 | 2,111 | 2,030 | 2,086 | -2 | -0.1% | 854,000 |
| 2024/05/24 | 2,082 | 2,128 | 2,050 | 2,088 | -74 | -3.4% | 925,800 |
| 2024/05/23 | 2,182 | 2,203 | 2,142 | 2,162 | -5 | -0.2% | 588,900 |
| 2024/05/22 | 2,193 | 2,240 | 2,152 | 2,167 | -86 | -3.8% | 1,022,300 |
| 2024/05/21 | 2,317 | 2,344 | 2,235 | 2,253 | -94 | -4% | 1,259,400 |
| 2024/05/20 | 2,128 | 2,383 | 2,122 | 2,347 | +169 | +7.8% | 2,263,800 |
| 2024/05/17 | 2,379 | 2,380 | 2,175 | 2,178 | -245 | -10.1% | 3,416,300 |
| 2024/05/16 | 2,572 | 2,583 | 2,308 | 2,423 | +1 | ±0% | 3,196,500 |
| 2024/05/15 | 2,437 | 2,454 | 2,390 | 2,422 | -30 | -1.2% | 1,511,400 |
251～
300
件表示中 / 3754件
類似銘柄と比較する
現在ご覧いただいている「ジーエヌアイ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| ジーエヌアイ | 279,200円 | +21.7% | +999.9% | 0.00% | 11.71倍 | 3.87倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 東和薬品 | 336,500円 | +7.9% | -3.3% | 2.38% | 9.36倍 | 0.97倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| サンバイオ | 236,000円 | - | - | 0.00% | - | 109.31倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 持田薬 | 323,000円 | +5.1% | -7.0% | 2.48% | 21.20倍 | 0.88倍 |
|
医薬中堅。高脂血症薬、降圧薬など循環器系得意。婦人科系にも強み。消化器系育成。化粧品も |
| ゼリア新薬 | 211,700円 | +3.1% | -6.5% | 2.27% | 9.82倍 | 1.04倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
